Peer-reviewed veterinary case report
Detecting symptomatic and asymptomatic dog leishmaniasis in Iran
By Mohammadi-Ghalehbin, Behnam et al.·Published in Iranian journal of immunology : IJI·2011·Shiraz University of Medical Sciences·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A Leishmania infantum FML-ELISA for the detection of symptomatic and asymptomatic canine visceral leishmaniasis in an endemic area of Iran.
- Species:
- dog
Plain-English summary
A group of dogs in Iran were tested for a disease called visceral leishmaniasis, which is caused by a parasite and can be serious. Out of 60 dogs, three showed symptoms like fever and weight loss, and they were confirmed to have the disease through blood tests. The new FML-ELISA test was able to detect the disease in these symptomatic dogs and also in some that didn't show symptoms. This test was found to be quite accurate, making it a good option for checking for this disease in dogs.
People also search for: dog leishmaniasis symptoms · how to test for leishmaniasis in dogs · treatment for dog with leishmaniasis
Abstract
BACKGROUND: Visceral leishmaniasis (VL) is caused by Leishmania infantum in Mediterranean basin and is an endemic disease in some parts of Iran. Canines are the main reservoirs of VL in most of the endemic areas. Different serological methods have been introduced for diagnosis of canine visceral leishmaniasis (CVL). OBJECTIVE: In this survey a Fucose-Mannose Ligand (FML) ELISA, using native L. infantum antigen, was developed and its validity for detection of infected dogs in comparison with direct agglutination test (DAT) and PCR was evaluated. METHODS: Blood samples of sixty ownership dogs (≤ 3 years old) were collected from Meshkin-shahr district in Ardabil province, North-west of Iran. Sera were separated for serological assays (DAT and FML-ELISA) and the buffy coats were collected for molecular evaluation. RESULTS: Two out of the 60 (3.33%) samples were found to be positive (antibody titer of ≥ 1/320) in DAT while seven of the 60 (11.66%) samples were positive by FML-ELISA. Nine out of 60 (15%) buffy coat samples showed a band about 680 bp indicative of L. infantum in PCR. Three out of 60 dogs had Kala-azar symptoms and were positive by PCR and FML-ELISA, while two of these three dogs had antibody titers >1/320 in their serum samples. The sensitivity and specificity of FML-ELISA for the detection of CVL in both symptomatic and asymptomatic dogs were found to be 77.8% and 100%, respectively. CONCLUSION: Considering the acceptable sensitivity and high specificity of FML-ELISA, use of this serological method can be recommended for epidemiological surveys of CVL.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/22201622/